Periodic reinterpretation of genetic sequencing results presents a challenge for developing transparent and systematic coverage and reimbursement policies.
José A. Pagán, PhD
Advertisement
Articles by José A. Pagán, PhD
This study investigates the cost-effectiveness of a community-based patient navigation program to improve cervical cancer screening.
Health system innovations are sometimes justified in economic language, but clinicians speak the language of patient care. Advancing reform requires translators who speak both languages.
Advertisement
Latest Updated Articles
- Reimbursement for Genetic Variant Reinterpretation: Five Questions Payers Should Ask
Published: October 14th 2021 | Updated:
- Do You Speak My Language? When Patient Care Meets Cost-Effectiveness
Published: June 12th 2015 | Updated:
- Cost-Effectiveness of a Patient Navigation Program to Improve Cervical Cancer Screening
Published: July 25th 2017 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
2
In Primary Care–Oncology Collaboration, the Baton Goes Both Ways
3
FDA Expands Evinacumab-dgnb Approval for Children as Young as 1 Year With HoFH
4
Marathon Health, Medbridge Partner to Launch Integrated Virtual MSK Care Program
5
